CV/COS Webinar: Applications and Future Directions

At Carevive, we believe that data is a powerful tool that can revolutionize cancer care. In this video, we explore the diverse applications of our data and how it can drive better outcomes for patients and clinicians alike.

One crucial application lies in supporting patient-reported outcome (PRO) measure selection for clinical trial planning. Our real-time data from a standard-of-care population offers contemporary insights into FDA-relevant domains. Unlike historical trial data that can quickly become outdated due to rapidly evolving oncology standards, our data ensures up-to-date and relevant measure selection.

Furthermore, our data serves as a bridge between real-world data and clinical trials. With PRO measures similar in domain coverage and assessment frequency, comparing patient experiences on treatment becomes more comparable, enabling apples-to-apples comparisons for efficacy, safety, and tolerability assessments.

The ability to analyze population-level differences and individual time course changes remotely is yet another valuable aspect of our data. This feature proves instrumental in profiling the impact of care management interventions and predicting risk factors.

Recent Episodes

For a long time, compliance in healthcare was tied to the survey cycle. Now, that model is shifting. With the introduction of Joint Commission 360, organizations are being asked to demonstrate continuous performance—not just preparedness. As patient safety comes under increasing scrutiny, The Joint Commission is moving toward an approach built on real-time data, traceability,…

Gone are the days when a hospital was simply a place where patients received care. Today’s hospitals are rapidly evolving into highly connected ecosystems powered by advanced technology, networked devices, and real-time data. The modern hospital is no longer confined to physical walls—it’s a dynamic digital environment where data flows seamlessly, AI supports clinical decisions,…

Healthcare providers across the U.S. are facing a growing wave of claim denials that is putting pressure on already strained hospital finances. Industry research from the American Hospital Association shows that nearly 15% of medical claims submitted to private payers are initially denied, forcing hospitals and health systems to spend about $19.7 billion annually attempting…